Literature DB >> 6363109

Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland.

F D Böhmer, W Lehmann, H E Schmidt, P Langen, R Grosse.   

Abstract

A growth inhibitor for Ehrlich ascites mammary carcinoma cells in vitro has been purified from bovine mammary gland. The purification procedure involving homogenization and differential centrifugation under hypotonic conditions, ammonium sulfate precipitation, ultrafiltration, gel chromatography and preparative polyacrylamide gel electrophoresis (PAGE) yielded an inhibitor showing half-maximal inhibition of cell proliferation in concentrations of 1-3 ng protein per ml. Upon 125I labelling and analysis by SDS gel electrophoresis, most purified preparations revealed a single band of 12-14 kD, likely to be representative for the inhibitory protein. The inhibitor was shown to affect resumption of proliferation of stationary cells; however, it was inactive towards cells stimulated by incubation with medium before adding the inhibitor. The inhibitor is heat-labile, does not act by exhausting essential components of culture medium, and its action is antagonized by insulin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363109     DOI: 10.1016/0014-4827(84)90591-3

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

Review 1.  Growth inhibitors: molecular diversity and roles in cell proliferation.

Authors:  K Miyazaki; T Horio
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

2.  Identification of Escherichia coli F4ac-binding proteins in porcine milk fat globule membrane.

Authors:  Predrag Novakovic; Yanyun Y Huang; Betty Lockerbie; Farshid Shahriar; John Kelly; John R Gordon; Dorothy M Middleton; Matthew E Loewen; Beverly A Kidney; Elemir Simko
Journal:  Can J Vet Res       Date:  2015-04       Impact factor: 1.310

3.  Modulation of the beta-adrenergic-response in cultured rat heart cells. II. Mammary-derived growth inhibitor (MDGI) blocks induction of beta-adrenergic supersensitivity. Dissociation from lipid-binding activity of MDGI.

Authors:  G Wallukat; F D Boehmer; U Engstroem; P Langen; M Hollenberg; J Behlke; H Kuehn; R Grosse
Journal:  Mol Cell Biochem       Date:  1991-03-27       Impact factor: 3.396

4.  Prostatic epithelium inhibiting factor (PEIF): organ specificity and production by prostatic fibroblasts.

Authors:  J J König; J C Romijn; F H Schröder
Journal:  Urol Res       Date:  1987

5.  Growth control in cultured 3T3 fibroblasts: neutralization and identification of a growth-inhibitory factor by a monoclonal antibody.

Authors:  Y M Hsu; J M Barry; J L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  HH2A, an immortalized bovine mammary epithelial cell line, expresses the gene encoding mammary derived growth inhibitor (MDGI).

Authors:  H Huynh; M Pollak
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

Review 7.  Growth control in mammalian cells by cell-cell contacts.

Authors:  R J Wieser; D Renauer; A Schäfer; R Heck; R Engel; S Schütz; F Oesch
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

8.  Growth control in cultured 3T3 fibroblasts. V. Purification of an Mr 13,000 polypeptide responsible for growth inhibitory activity.

Authors:  Y M Hsu; J L Wang
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

9.  Evaluation of inhibition of F4ac positive Escherichia coli attachment with xanthine dehydrogenase, butyrophilin, lactadherin and fatty acid binding protein.

Authors:  Predrag Novakovic; Chandrashekhar Charavaryamath; Igor Moshynskyy; Betty Lockerbie; Radhey S Kaushik; Matthew E Loewen; Beverly A Kidney; Chris Stuart; Elemir Simko
Journal:  BMC Vet Res       Date:  2015-09-15       Impact factor: 2.741

10.  Members of the fatty acid binding protein family are differentiation factors for the mammary gland.

Authors:  Y Yang; E Spitzer; N Kenney; W Zschiesche; M Li; A Kromminga; T Müller; F Spener; A Lezius; J H Veerkamp
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.